NCT03424694View on ClinicalTrials.gov

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

June 22, 2015

Primary Completion Date

June 22, 2019

Study Completion Date

February 22, 2022

Conditions
Prostate Cancer
Interventions
RADIATION

HDR brachytherapy as monotherapy

Trial Locations (1)

J4V 2H1

Hôpital Charles LeMoyne, Greenfield Park

All Listed Sponsors
lead

CR-CSSS Champlain-Charles-Le Moyne

OTHER

NCT03424694 - HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer | Biotech Hunter | Biotech Hunter